Synapse - Andrew Lassman

Results (29)

YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma

Journal Article

Hottinger, A. F.; Iwamoto, F. M.; Karimi, S.; Riedel, E.; Dantis, J.; Park, J.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
Annals of Neurology (2011)

Fulltext@MSK | Save

Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma

Journal Article

Gupta, A.; Young, R. J.; Karimi, S.; Sood, S.; Zhang, Z.; Mo, Q.; Gutin, P. H.; Holodny, A. I.; Lassman, A. B.
American Journal of Neuroradiology (2011)

Fulltext@MSK | Save

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

Journal Article

Lassman, A. B.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; Ashby, L. S.; more...
Neuro-Oncology (2011)

Fulltext@MSK | Save

Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma

Journal Article

Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)

Meeting Abstract

Sul, J.; Panageas, K. S.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Grimm, S. A.; DeAngelis, L. M.; Abrey, L. E.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Clinical and molecular-metabolic phase II trial of perifosine for recurrent/progressive malignant glioma

Meeting Abstract

Lassman, A.; Holland, E.; DeAngelis, L.; Panageas, K.; Abrey, L.
Neuro-Oncology (2007)

Fulltext@MSK | Save

A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)

Meeting Abstract

Clarke, J.; Sul, J.; DeAngelis, L.; Lassman, A.; Hormigo, A.; Nolan, C.; Gavrilovic, I.; Gu, B.; Panageas, K.; Abrey, L.
Neuro-Oncology (2007)

Fulltext@MSK | Save

Systemic high-dose intravenous methotrexate for central nervous system metastases

Journal Article

Lassman, A. B.; Abrey, L. E.; Shah, G. D.; Panageas, K. S.; Begemann, M.; Malkin, M. G.; Raizer, J. J.
Journal of Neuro-Oncology (2006)

Fulltext@MSK | Save

Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice

Journal Article

Lassman, A. B.; Dai, C.; Fuller, G. N.; Vickers, A. J.; Holland, E. C.
Neuron Glia Biology (2004)

Fulltext@MSK | Save